Equal Ventures

Pureland Global Venture is a direct investment fund and part of the Pureland Group which targets impact investment deals in the medical technology sector. We are Singapore-based with a focus in APAC, India and the US. The fund deals with early-stage companies who have potential to inject value into the patient care system, save lives and reduce gaps in the supply and demand chains. Since we were established, we have invested in multiple medical sectors in both medical devices and ML-based solutions. MISSION - WHAT WE WANT TO ACHIEVE Established with the goal of giving people access to healthcare and also providing them with clinical choices, our mission is to bring medical solutions and savings to 100 million people around the world. We strongly believe in people who don’t just care about profit and who want to make the world a better place by solving real issues and pushing forward the latest evolution in medical technology. We envision bringing together impactful start-ups, commercial partners, insightful advisors and clinical providers in order to build a sustainable foundation for affordable, accessible and high-quality healthcare. WHY HEALTHCARE? Worldwide healthcare spending is expected to continue to rise at an alarming rate with a slight difference in some countries. Of all the leading factors, life expectancy appears to still be on the rise. By 2050, 1/6 people in the world will be over the age of 65 (16%), an increase from 1/11 in 2019 (9%). The number of people aged over 80 is projected to be 426 million by 2050 according to the United Nations population prospects. As we are entering a smart-health generation, the ecosystem demands more cost-effective solutions and appropriate treatments which can be delivered at the appropriate time and location. Clinicians use technology to give more holistic solutions to an aging population and provide more accurate diagnostics. Care delivery stakeholders use data and communicate more effectively and efficiently. Patients are involved in their own treatment plans and more healthcare access is delivered to people who did not previously have access. Unfortunately, we still face issues such as the increasing cost of healthcare, aging population, limited resources and shortages of healthcare professionals in various parts of the world. In order to combat these problems, government support and spending alone is not enough. We believe that these shortages can be filled by technology, which can be our solution for ensuring sufficient healthcare for future generations. This is also the reason why we are keen on enterprises which can provide solutions to combat these issues and create positive changes in the smart-health era. Founded in Singapore, we hope to be able to leverage the geographical advantage of Asia, and put together growth opportunities for these technologies which will make them accessible globally in the long term. WE SUPPORT START-UPS POST INVESTMENTFOUNDER SUPPORT: Start-ups regularly face critical decision-making as businesses grow from continuous market feedback and unexpected situations. We understand how difficult it can be and we will work together with the founders as a team in order to assist them with scaling their company, whether from networking referrals at the R&D stage, business strategy improvement at the growth stage, or EBITDA optimisation at a later stage. We offer support to founders for the optimisation of team structure as their businesses grow so they can overcome challenges and compete globally. MANUFACTURING SUPPORT: Manufacturing is one of the most crucial aspects of any device company, but it is often where mistakes are made. We advise our companies who experience manufacturing challenges from prototyping to mass production. In order to achieve this, we provide strategic value to our portfolio companies by connecting them to cost-effective manufacturing partners throughout the plastic, PCBA, silicon/rubber and final assembly industries. Our partners are high-mix and low-volume suppliers who understand the challenges of start-ups. Outside of production, we assist companies with lower case costing, set-up and management. GOVERNANCE: Establishing a good corporate culture and necessary internal control will mitigate business losses from major risks and lay the foundations for a company to improve. In a later stage funding cycle, correct corporate governance and internal control are paramount before larger funds buy into the company’s vision and growth story. We have a complete understanding of control and our networks are comprised of global experts in financial knowledge and risk assurance who can work together with our companies. FUNDRAISING: We typically fund companies while they are still young, from their seed to their series A round. Given the heavy research and development nature of medical technology companies, they usually require additional funding in order to boost their business quickly. Post-investment, we will not only collaborate on budgets and milestone adjustments but will more importantly offer assistance with financial modeling and revenue projection. This ensures that companies gain a higher chance of future investment. Finally, we work with other larger funds all over the world who specialise in revenue growth in order to understand their needs when they select their investment targets. EXIT: We seek founders with longer-term goals and a desire to take their companies to global players. Given our evergreen nature and flexible exit strategy, we are well suited to the long operation cycle of healthcare companies. At the same time, we understand and respect that some founders have a shorter term goal of M&A to boost market shares, expand business services or leverage bigger players to scale the company. We are experienced in company buy-out considerations and offer our support to founders as long as the company fits within our investment mandate.

We focus on early-stage companies and breakthrough technologies that enable the transition from linear to circular models, particularly within the Consumer & Retail sectors. Our dual approach ensures that ventures receive not only capital but also structured growth support through “The House of Circularity” platform. This platform brings together startups, corporations, and investors to pilot, validate, and scale solutions that deliver positive, measurable, and profitable results from initial testing to market expansion. Spin Ventures differentiates itself by integrating capital investment with data-driven acceleration through “The House of Circularity”. Our focus on circular economy markets and strong corporate partnerships ensures ventures deliver quantifiable financial returns and measurable impact. We align the goals of startups, corporates, and investors to implement circular and regenerative models that bring operational efficiencies, increased revenues, and a reduction in carbon emissions across industries. Spin Ventures is committed to leading the transition towards a circular and regenerative economy by combining investment, acceleration, and “The House of Circularity” platform. Our approach meets immediate market needs while positioning companies for sustained growth in a changing regulatory environment. By uniting startups, investors, and corporations through a structured ecosystem, we drive measurable impact, operational efficiencies, profitability, and decarbonization of supply and value chains. Are you a Founder, Investor, or Corporate leader ready to accelerate the transition to a circular economy? We invite you to join us in driving measurable impact and profitable growth. Reach out to us at hello@spin.vc to explore how we can work together to accelerate the transition towards a circular and regenerative economy or as we say “to spin the world”. Let’s create tangible results and shape the next generation of circular innovation - together. FOR INVESTORS Through our diversified strategies, we give access to high-growth markets in circular supply chains, regenerative materials, and re-commerce, with targeted returns driven by regulatory trends and market demand. “The House of Circularity” mitigates risks through structured pilot programs, scaling successful models alongside corporate partners to maximize impact and profitability. FOR FOUNDERS Beyond funding, we offer a pathway to growth through “The House of Circularity”. This platform provides startups with practical resources, industry connections, and quantifiable metrics to navigate market and regulatory landscapes, optimizing operational efficiencies, generating incremental revenues, and enhancing profitability. FOR CORPORATIONSr We facilitate partnerships that implement circular practices into existing business models, driving operational efficiencies and unlocking new revenue opportunities. “The House of Circularity” platform enables companies to pilot innovations that decarbonize their supply and value chains, ensuring scalable and profitable outcomes.

Agility Ventures is the corporate venture arm of Agility, a leader in supply chain services, innovation and investing. We partner with companies that are championing technology that will be the foundation for faster, cleaner, fairer and stronger supply chains. We focus our investments on sustainability, eCommerce enablement, digital supply chain, and disruptive technologies.

Red Sea Ventures is a leading NY-based, pre-seed and seed stage venture firm investing in tech-enabled, user-centric consumer and B2B startups. In our first fund, we invested in category leading companies across sectors including Allbirds, Convoy, Nest, Eargo, Prose, Genies, Joor, and Sweetgreen. We are looking to partner with mission driven founders seeking to transform the economy and the lives of their teams and users. We are an entrepreneurial firm that values friendliness, humility, camaraderie, collaboration, determination, independence, and hustle with a commitment to performance. We are building RSV as a platform for community; bringing together our visionary founders, LPs, and relationships at large to support the companies we choose to partner with.

The companies and founders we back are building the tools, products, and services that define the future of inclusive work, the new care economy, and the next wave of financial progress. Our investments center on 3 core themesReforming and re-imagining work to enable fair, flexible, and dignified careers Building connected, innovative solutions for children, older adults, and women's health Supporting the sustainability, efficiency, and financial security of households and communities The Builders We back exceptional founders with unique real-world experiences from all backgrounds and identities. We invest pre-seed through series A in world-class teams of all genders and backgrounds.

We build and invest in companies that positively impact human health with smart solutions, breakthrough science and technology. Our focus is on innovation in digital healthcare, connected medical devices, and life sciences We focus on therapeutic and preventive technology solutions addressing unmet needs in some of the most vulnerable segments of society: women, children and the elderly. Digital transformation will continue to shape our lives and has the potential to transform care. We aim to build and support Digital Health & Life Sciences companies working to make healthcare smarter, using data to improve care and outcomes, and reinventing the patient journey. Our vision for the future of healthcare guides our investment strategy. A data driven digital transformation will shape the future of healthcare. The traditional biopharma model will evolve into an integrated model, where prevention, precision cure, and care management will coexist in a highly personalized patient-centric solution. Our goal is to support the creation of life transforming care products and therapies. We believe the future of healthcare lies in supporting the next-generation of founders and teams who will lead us there. What do we look for?Innovation and groundbreaking opportunities in our sectors of focus: digital health, life sciences, tech-enabled care delivery, and connected devices Innovative treatments for Central Nervous System (CNS) disorders, in particular neurodevelopmental disorders, mental health and epilepsy Founders and teams with domain expertise who seek collaborative investment partners Investments that span development and commercial phases, with a focus on early stage opportunities (Pre-Seed to Series A). Our investment approachOur investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective. We invest primarily across Europe, North America and Israel, recognizing that healthcare technology innovation is occurring in many cities around the world. We have committed €300M for investments and company creation in digital health and life sciences. What do we commit to you?Active and involved healthcare investors who operate with integrity, approachability, and transparency A team of passionate healthcare and venture capital experts diverse in demographic and experience A track record of success and experience navigating the ups and downs of early-stage company building Access to a world-class advisory board to leverage C-level experience, expertise, and leadership in healthcare